Guardion Health Sciences, Inc. (GHSI) News
Filter GHSI News Items
GHSI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
GHSI News Highlights
- For GHSI, its 30 day story count is now at 3.
- Over the past 18 days, the trend for GHSI's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- USER are the most mentioned tickers in articles about GHSI.
Latest GHSI News From Around the Web
Below are the latest news stories about Guardion Health Sciences Inc that investors may wish to consider to help them evaluate GHSI as an investment opportunity.
Guardion Health Sciences launches online store for ViactivGuardion Health Sciences (GHSI) a clinical nutrition company, has announced the launch of its new branded Shopify store for its Viactiv line of products |
Guardion Health Sciences Launches New Online Store for ViactivNew e-commerce venue to offer all Viactiv products and additional educational content to enhance user experienceHOUSTON, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, today announced the launch of its new branded Shopify store for its Viactiv line of products, https://viactiv.com. The new e-commerce venue offers Viactiv custom |
Guardion Health Sciences to Present at the H.C. Wainwright Bioconnect 2022 Virtual ConferenceHOUSTON, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, announces today that Chief Executive Officer Bret Scholtes will present a corporate overview at the H.C. Wainwright Bioconnect 2022 Virtual Conference, which is taking place on January 10 – 13, 2022. The presentation will be available on-demand to registered attendees of the conference beginning at 7:0 |
Guardion Health Sciences to Wind Down VectorVision Business Operations and Focus on Exploiting VectorVision Intellectual PropertyManagement Anticipates $300,000+ Reduction in Annual Operating Costs Management Anticipates $300,000+ Reduction in Annual Operating Costs |
Guardion Health Sciences Issues Letter to ShareholdersHOUSTON, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements, and medical devices, issued the following Letter to Shareholders: Dear Fellow Shareholders, I am delighted to be able to communicate directly with you and share all the developments that have occurred involving Guardion over the last year. During the course of |
Guardion Health Sciences Appoints Experienced Healthcare Executive Michaela Griggs to its Board of DirectorsHOUSTON, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (Guardion or the Company), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements, and medical devices, announced today that Michaela Griggs, a seasoned healthcare executive, has been appointed to its Board of Directors. |
Guardion Health Sciences to Present at the Benzinga Global Small Cap ConferenceHOUSTON, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements, and medical devices, announces today that Chief Executive Officer Bret Scholtes will present a corporate overview at the Benzinga Global Small Cap Conference, which is being held virtually on December 8 – 9, 2021. Mr. Scholtes will deliver his corporate present |
Vanguard Group Inc. Raises Stock Position in Guardion Health Sciences, Inc. (NASDAQ:GHSI)Vanguard Group Inc. raised its stake in Guardion Health Sciences, Inc. (NASDAQ:GHSI) by 83.2% in the second quarter, HoldingsChannel reports. The institutional investor owned 1,069,815 shares of the companys stock after buying an additional 485,870 shares during the quarter. Vanguard Group Inc.s holdings in Guardion Health Sciences were worth $1,883,000 at the end of the [] |
Selling Your Guardion Health Sciences Inc. (NASDAQ: GHSI) Stock? Heres What You Need To KnowGuardion Health Sciences Inc. (NASDAQ:GHSI) shares, rose in value on Wednesday, 11/24/21, with the stock price up by 1.85% to the previous days close as strong demand from buyers drove the stock to $1.10. Actively observing the price movement in the last trading, the stock closed the session at $1.08, falling within a range of Selling Your Guardion Health Sciences Inc. (NASDAQ: GHSI) Stock? Heres What You Need To Know Read More » |
Guardion Health Sciences reports Q3 resultsNo summary available. |